Search Results - "Aldvén, M" :: K.UTB vyhledávací portál

Loading…

EE649 Cost Per Responder of Bimekizumab Against Il-17A, IL-12/23 and IL-23 Inhibitors in the Treatment of Psoriatic Arthritis in Sweden

by Lyris, N., Geale, K., Aldvén, M., Engström, A., Willems, D.
Published in Value in health (01.12.2023)

Get full text

Journal Article

Loading…

EE337 Cost-Effectiveness of Nirmatrelvir/Ritonavir in High-Risk Swedish Adults Including Post-Acute COVID Syndrome (PACS) From a Societal Perspective

by Aldvén, M., Kądziela, M., Gerdesköld, C., Arash Rahimi, A., Nilsson, F.
Published in Value in health (01.12.2023)

Get full text

Journal Article

Loading…

EPH120 Clinical and Economic Burden of Severe Pneumococcal Disease Among Adults in Sweden: A Population-Based Register Study

by Zarabi, N, Aldvén, M, Sjölander, S, Fues Wahl, H, Bencina, G, Johnson, KD, Silfverdal, SA
Published in Value in health (01.12.2022)

Get full text

Journal Article

Loading…

P054 Clinical outcomes in people with cystic fibrosis treated with lumacaftor/ivacaftor in routine clinical practice in Sweden

by Lindblad, A., de Monestrol, I., Gilljam, M., Lindberg, U., Krantz, C., Klackenberg, A., McGarry, L.J., Bhaiwala, Z., Borgström, F., Banefelt, J., Danielsson, L., Aldvén, M.
Published in Journal of cystic fibrosis (2021)

Get full text

Journal Article

Loading…

Healthcare resource use and costs among patients with primary sclerosing cholangitis in Sweden-a retrospective population-based cohort study

by Bergquist, Annika, Kachru, Nandita, Aldvén, Martina, Ström, Oskar, Knutsson, Douglas, Grip, Emilie Toresson, Hagström, Hannes
Published in JOURNAL OF HEPATOLOGY (01.06.2023)

Get full text

Journal Article Conference Proceeding

Loading…

Clinical, economic, and societal burden of cystic fibrosis and the impact of the CFTR modulator, lumacaftor/ivacaftor: an assessment using linked registry data in Sweden

by Lindblad, Anders, Monestrol, Isabelle de, Gilljam, Marita, Krantz, Christina, McGarry, Lisa J, Banefelt, Jonas, Aldvén, Martina
Published in Journal of medical economics (2024)

Get full text

Journal Article

EE649 Cost Per Responder of Bimekizumab Against Il-17A, IL-12/23 and IL-23 Inhibitors in the Treatment of Psoriatic Arthritis in Sweden

EE337 Cost-Effectiveness of Nirmatrelvir/Ritonavir in High-Risk Swedish Adults Including Post-Acute COVID Syndrome (PACS) From a Societal Perspective

EPH120 Clinical and Economic Burden of Severe Pneumococcal Disease Among Adults in Sweden: A Population-Based Register Study

P054 Clinical outcomes in people with cystic fibrosis treated with lumacaftor/ivacaftor in routine clinical practice in Sweden

Healthcare resource use and costs among patients with primary sclerosing cholangitis in Sweden-a retrospective population-based cohort study

Clinical, economic, and societal burden of cystic fibrosis and the impact of the CFTR modulator, lumacaftor/ivacaftor: an assessment using linked registry data in Sweden

Refine Results

Format

Subject Area

Topic

Language

Year of Publication

Database